Data / Form D filings / TheraVasc Inc.
TheraVasc Inc.: Form D filings
TheraVasc Inc., a pharmaceuticals company in Cleveland, OH, filed 4 Form D notices with the SEC between 2009 and 2014. The latest, on March 18, 2014, reports $350,000 sold of a $2 million offering to 1 investor.
Find out what TheraVasc Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10000 CEDAR AVENUE, GCIC2-MS#1, Cleveland, OH, 44106
- Phone
- (318) 349-3851
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2009
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1479295
The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2014 | New notice | $2,000,000 | $350,000 | $1,650,000 | 1 | Mar 10, 2014 | sec.gov |
| Nov 15, 2013 | New notice | $1,000,000 | $172,501 | $827,499 | 10 | Jun 1, 2013 | sec.gov |
| Sep 27, 2010 | New notice | $2,250,000 | $1,836,996 | $413,004 | 20 | Sep 14, 2010 | sec.gov |
| Dec 28, 2009 | New notice | $350,000 | $250,000 | $100,000 | 1 | Dec 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kyle Chan | Director | |
| Anthony Giordano | Executive Officer, Director | |
| John Huston | Director | |
| John Zak | Director | |
| Susan Luria | Director |
Other pharmaceuticals companies in Ohio that filed recently
- EIKONOKLASTES THERAPEUTICS, INC. $16.1 million · Oct 6, 2026
Every Form D from the week of Mar 17, 2014 · All recent filings in Ohio · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TheraVasc Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.